CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	418.86	418.51	353.92	1,144	-
Short-Term Investments	6.22	1.76	-	1.88	-
Cash & Short-Term Investments	425.08	420.27	353.92	1,146	-
Cash Growth	42.33%	18.75%	-69.11%	-	-
Accounts Receivable	733.03	864.51	800.92	890.34	-
Other Receivables	250.44	227.52	187.81	230.53	-
Receivables	998.09	1,105	1,001	1,132	-
Inventory	577.54	640.51	645.18	654.64	-
Prepaid Expenses	18.21	4.58	14.09	8.42	-
Total Current Assets	2,072	2,171	2,014	2,941	-
Property, Plant & Equipment	6,211	6,317	6,705	7,078	-
Other Intangible Assets	63.24	60.64	60.13	55.62	-
Long-Term Accounts Receivable	135.5	135.79	138.41	135.05	-
Long-Term Deferred Tax Assets	2.2	2.4	3.45	-	-
Other Long-Term Assets	-	-	-	2.61	-
Total Assets	8,505	8,707	8,944	10,235	-
Accounts Payable	387.37	68.79	62.54	87.67	-
Accrued Expenses	9.43	246.19	204.23	238.6	-
Current Portion of Leases	9.21	9.04	8.33	4.49	-
Current Income Taxes Payable	50.07	47.31	49.87	40.27	-
Current Unearned Revenue	-	20.49	19.45	33.04	-
Other Current Liabilities	535.76	542.68	556.11	624.08	-
Total Current Liabilities	991.84	934.51	900.53	1,028	-
Long-Term Debt	2,953	2,950	3,153	3,984	-
Long-Term Leases	156.23	158.08	162.29	158.88	-
Long-Term Deferred Tax Liabilities	94.41	85.14	54.51	33.27	-
Other Long-Term Liabilities	-	-	34.39	67.44	-
Total Liabilities	4,290	4,225	4,398	5,366	-
Common Stock	4,809	4,809	4,809	4,809	-
Retained Earnings	3,717	3,896	3,971	4,280	-
Comprehensive Income & Other	-4,242	-4,243	-4,248	-4,241	-
Total Common Equity	4,194	4,463	4,532	4,848	-
Minority Interest	21.85	19.34	13.35	21.59	-
Shareholders' Equity	4,215	4,482	4,546	4,870	-
Total Liabilities & Equity	8,505	8,707	8,944	10,235	-
Total Debt	3,118	3,117	3,324	4,147	-
Net Cash (Debt)	-2,693	-2,697	-2,970	-3,002	-
Net Cash Per Share	-0.09	-0.09	-0.10	-0.10	-
Filing Date Shares Outstanding	29,927	30,058	30,058	30,058	-
Total Common Shares Outstanding	29,927	30,058	30,058	30,058	-
Working Capital	1,080	1,236	1,114	1,913	-
Book Value Per Share	0.14	0.15	0.15	0.16	-
Tangible Book Value	4,130	4,402	4,472	4,792	-
Tangible Book Value Per Share	0.14	0.15	0.15	0.16	-
Buildings	717.84	716.77	720.2	708.39	-
Machinery	13,105	12,960	12,892	12,635	-
Construction In Progress	262.62	257.27	207.84	322.2	-

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.